全文获取类型
收费全文 | 2581175篇 |
免费 | 189251篇 |
国内免费 | 7554篇 |
专业分类
耳鼻咽喉 | 34262篇 |
儿科学 | 85164篇 |
妇产科学 | 71561篇 |
基础医学 | 363474篇 |
口腔科学 | 69637篇 |
临床医学 | 234226篇 |
内科学 | 514800篇 |
皮肤病学 | 62442篇 |
神经病学 | 213334篇 |
特种医学 | 99860篇 |
外国民族医学 | 736篇 |
外科学 | 386323篇 |
综合类 | 50369篇 |
现状与发展 | 5篇 |
一般理论 | 968篇 |
预防医学 | 195854篇 |
眼科学 | 56610篇 |
药学 | 187923篇 |
8篇 | |
中国医学 | 5331篇 |
肿瘤学 | 145093篇 |
出版年
2021年 | 19975篇 |
2019年 | 20614篇 |
2018年 | 29276篇 |
2017年 | 22587篇 |
2016年 | 26221篇 |
2015年 | 29501篇 |
2014年 | 40437篇 |
2013年 | 60424篇 |
2012年 | 80220篇 |
2011年 | 84481篇 |
2010年 | 50999篇 |
2009年 | 49142篇 |
2008年 | 79018篇 |
2007年 | 83828篇 |
2006年 | 85565篇 |
2005年 | 81730篇 |
2004年 | 78721篇 |
2003年 | 76041篇 |
2002年 | 73331篇 |
2001年 | 128406篇 |
2000年 | 131333篇 |
1999年 | 110500篇 |
1998年 | 31254篇 |
1997年 | 27920篇 |
1996年 | 28217篇 |
1995年 | 27383篇 |
1994年 | 25068篇 |
1993年 | 23420篇 |
1992年 | 85160篇 |
1991年 | 81563篇 |
1990年 | 78784篇 |
1989年 | 76063篇 |
1988年 | 69468篇 |
1987年 | 67997篇 |
1986年 | 63542篇 |
1985年 | 60511篇 |
1984年 | 44940篇 |
1983年 | 37944篇 |
1982年 | 22458篇 |
1981年 | 19985篇 |
1979年 | 38959篇 |
1978年 | 27439篇 |
1977年 | 23252篇 |
1976年 | 21495篇 |
1975年 | 22813篇 |
1974年 | 26786篇 |
1973年 | 25370篇 |
1972年 | 23749篇 |
1971年 | 21955篇 |
1970年 | 20183篇 |
排序方式: 共有10000条查询结果,搜索用时 593 毫秒
11.
Syed M. Gilani Muhammad Khan Andrea Barbieri Manju L. Prasad 《Diagnostic Histopathology》2021,27(6):263-271
Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid malignancy with high mortality rate. This malignancy arises in thyroid follicular cells either denovo or with an associated differentiated thyroid carcinoma component. Clinically, it usually presents as a rapidly enlarging mass, pain and locally compressive symptoms. Histopathologic variability and heterogeneity often pose diagnostic challenges, especially in scant and paucicellular specimens. This article describes the clinical, histopathologic and molecular features of ATC and also addresses the associated diagnostic limitations and challenges. 相似文献
12.
Qian Zhang Larry D. Mesner Gina M. Calabrese Naomi Dirckx Zhu Li Angela Verardo Qian Yang Robert J. Tower Marie-Claude Faugere Charles R. Farber Thomas L. Clemens 《The Journal of clinical investigation》2021,131(7)
Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass. 相似文献
13.
14.
15.
Immunoglobulin light chain amyloidosis (AL) commonly presents with nephrotic range proteinuria, heart failure with preserved ejection fraction, nondiabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea, and should be considered in patients presenting with these symptoms. More importantly, patients being monitored for smoldering multiple myeloma and a monoclonal gammopathy of undetermined significance (MGUS) are at risk for developing AL amyloidosis. MGUS and myeloma patients that have atypical features, including unexplained weight loss; lower extremity edema, early satiety, and dyspnea on exertion should be considered at risk for light chain amyloidosis. Overlooking the diagnosis of light chain amyloidosis leading to therapy delay is common, and it represents an error of diagnostic consideration. Herein we provide a review of established and investigational treatments for patients with AL amyloidosis and provide algorithms for workup and management of these patients.Subject terms: Myeloma, Chemotherapy 相似文献
16.
17.
18.
19.
20.